scispace - formally typeset
E

Eyk Schellenberger

Researcher at Charité

Publications -  65
Citations -  2833

Eyk Schellenberger is an academic researcher from Charité. The author has contributed to research in topics: Annexin A5 & Iron oxide nanoparticles. The author has an hindex of 24, co-authored 65 publications receiving 2650 citations. Previous affiliations of Eyk Schellenberger include Humboldt University of Berlin & Harvard University.

Papers
More filters
Journal ArticleDOI

Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V–Cy5.5 conjugate

TL;DR: It is shown that tumor response to chemotherapy can be accurately resolved by fluorescence molecular tomography (FMT) with a phosphatidylserine-sensing fluorescent probe based on modified annexins, thus confirming tomographic imaging as a preferred tool for quantitative investigations of fluorescent probes in tissues.
Journal ArticleDOI

Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle.

TL;DR: The ability to image cardiomyocyte apoptosis in vivo with high‐resolution MRI with the novel nanoparticle AnxCLIO‐Cy5.5 is demonstrated to facilitate the development of novel cardioprotective therapies.
Journal Article

Near-Infrared Fluorescent Imaging of Tumor Apoptosis

TL;DR: It is demonstrated that active Cy-annexin can be used as a NIRF probe to image apoptosis from outside an intact living animal and may provide nonradioactive method of measuring the antiproliferative effects of cancer chemotherapeutic regimens.
Journal ArticleDOI

Magneto/optical annexin V, a multimodal protein.

TL;DR: The synthesis of a magneto/optical form of annexin V is described, achieved by reacting the amino-CLIO nanoparticle with Cy5.5 and SPDP, to produce a fluorescent, sulfhydryl reactive nanoparticle that preserved the protein's ability to bind apoptotic Jurkat T cells.
Journal ArticleDOI

Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.

TL;DR: Conjugation of annexin V to CLIO affords a strategy for the development of a MRI imaging probe for detecting apoptosis and allowed the identification of cell suspensions containing apoptotic cells by MRI even at very low concentrations of magnetic substrate.